|
COPYRIGHT 2004 International Medical News Group
ROCKVILLE, MD. -- The Food and Drug Administration has reassured pharmaceutical companies that they can use radiofrequency identification technology in product packaging without running afoul of agency rules, at least through 2007.
"Today's actions were designed with one goal in mind: to increase the safety of medications consumers receive by creating the capacity to track a drug from the manufacturer all the way to the pharmacy," acting FDA Commissioner Lester M. Crawford, D.V.M., Ph.D., said at a press briefing sponsored by the FDA.
At the same time, Purdue Pharma LP, Pfizer, and...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
